Vama Health World LLP — Olaparib Exporter Profile
Indian Pharmaceutical Exporter · #3 for Olaparib · $107.6K export value · DGFT Verified
Vama Health World LLP is the #3 Indian exporter of Olaparib with $107.6K in export value and 20 verified shipments. Vama Health World LLP holds a 11.7% market share in Olaparib exports across 2 countries. The company exports 3 pharmaceutical products worth $246.6K across 2 therapeutic categories.
Vama Health World LLP — Olaparib Export Profile: Buyers & Destinations
Where Does Vama Health World LLP Export Olaparib?
| Country | Value | Shipments | Share |
|---|---|---|---|
| SWITZERLAND | $78.2K | 14 | 72.6% |
| BAHAMAS | $29.5K | 6 | 27.4% |
Vama Health World LLP exports Olaparib to 2 countries. The largest destination is SWITZERLAND accounting for 72.6% of Vama Health World LLP's Olaparib shipments. These destinations reflect Vama Health World LLP's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Olaparib from Vama Health World LLP?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AS PER INVOICE AS | SWITZERLAND | $33.9K | 9 |
| AS PER INVOICE ASPER INVOICE | BAHAMAS | $29.5K | 6 |
| AS PER INVOICE | SWITZERLAND | $14.7K | 1 |
| TO THE EXP CODE E0187FARMACIA INTERNAZIONALE BORDONI SA | SWITZERLAND | $9.8K | 2 |
Vama Health World LLP supplies Olaparib to 4 buyers globally. The largest buyer is AS PER INVOICE AS (SWITZERLAND), followed by AS PER INVOICE ASPER INVOICE (BAHAMAS) and AS PER INVOICE (SWITZERLAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Olaparib Export Value and How Much Does Vama Health World LLP Contribute?
India exported $787.0K worth of Olaparib through 307 shipments from 70 suppliers to 49 countries, serving 99 buyers globally. Vama Health World LLP contributes $107.6K to this total, accounting for 11.7% of India's Olaparib exports. Vama Health World LLP ships Olaparib to 2 countries through 4 buyers.
What Is the Average Shipment Value for Vama Health World LLP's Olaparib Exports?
Vama Health World LLP's average Olaparib shipment value is $5.4K per consignment, based on 20 shipments totaling $107.6K. The largest destination is SWITZERLAND (72.6% of Vama Health World LLP's Olaparib exports).
How Does Vama Health World LLP Compare to Other Indian Olaparib Exporters?
Vama Health World LLP ranks #3 among 70 Indian Olaparib exporters with a 11.7% market share. The top 3 exporters are BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED ($285.6K), SANDOZ PRIVATE LIMITED ($161.9K), VAMA HEALTH WORLD LLP ($107.6K). Vama Health World LLP processed 20 shipments to 2 destination countries.
What Olaparib Formulations Does Vama Health World LLP Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONTABS. OLAPARIB 150 MG BATCH NO. SH763 MANUFACTURING DATE. AUG-22 EXP DATE. JUL-26 | $19.6K | 2 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONTABS. OLAPARIB 150 MG BATCH NO. SJ701MFG DATE. 11/2022 EXP DATE. 10/202NOS | $14.7K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONTABS OLAPARIB 100 MG TABS LYNPARZA 100 MG BATCH NO SF244 MFG DATE JAN 22 | $9.9K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONTABS OLAPARIB 100 MG TABS LYNPARZA 100 MG BATCH NO SB003 MFG DATE MAY 21 | $9.9K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONTABS. OLAPARIB 150MG BATCH NO. SF897 MANUFACTURING DATE. 01/2022 EXP DATE. 12/2025 | $7.3K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONTABS. OLAPARIB 100 MG BATCH NO. SG455 MANUFACTURING DATE. MAY-22 EXP DATE. APR-26 | $6.6K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONTABS. OLAPARIB 150 MG BATCH NO. SG973 MANUFACTURING DATE. JUL-22 EXP DATE. JUN-26 | $4.9K | 2 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONTABS. OLAPARIB 150 MG BATCH NO. SG542 MANUFACTURING DATE. FEB-22 EXP DATE. JAN-26 | $4.9K | 2 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONTABS. OLAPARIB 100MG BATCH NO. SH736 MANUFACTURING DATE. 07/2022 EXP DATE. 06/2026 | $4.8K | 1 |
| HARMLESS MEDICINE FOR HUMAN CONSUMPTIONTABS. OLAPARIB 150MG BATCH NO. SG541 MANUFACTURING DATE. 03/2022 EXP DATE. 02/2026 | $4.8K | 1 |
Vama Health World LLP exports 17 distinct Olaparib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is HARMLESS MEDICINE FOR HUMAN CONSUMPTIONTABS. OLAPARIB 150 MG with 2 shipments worth $19.6K.
How Does Vama Health World LLP Compare to Nearest Olaparib Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED | $285.6K | 15 | 2 | $19.0K |
| 2 | SANDOZ PRIVATE LIMITED | $161.9K | 57 | 2 | $2.8K |
| 3 | VAMA HEALTH WORLD LLP ★ | $107.6K | 20 | 2 | $5.4K |
| 4 | SPECIALITY MEDICINES LIMITED | $76.4K | 15 | 2 | $5.1K |
| 5 | SP ACCURE LABS PRIVATE LIMITED | $40.4K | 3 | 1 | $13.5K |
Vama Health World LLP ranks #3 among 70 Indian Olaparib exporters. Average shipment value of $5.4K compared to the market average of $11.2K. The closest competitors by value are BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED and SANDOZ PRIVATE LIMITED.
Which Indian Ports Ship Olaparib Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 120 | 39.1% |
| SAHAR AIR | 56 | 18.2% |
| HYDERABAD ACC (INHYD4) | 17 | 5.5% |
| Bombay Air Cargo | 17 | 5.5% |
| AHEMDABAD AIR ACC (INAMD4) | 16 | 5.2% |
| Bombay Air | 12 | 3.9% |
| HYDERABAD AIR | 9 | 2.9% |
| Hyderabad Air | 8 | 2.6% |
What Other Advanced Oncology Products Does Vama Health World LLP Export?
Vama Health World LLP also exports these advanced oncology products. Each links to the detailed product page.
About Vama Health World LLP
Vama Health World LLP exports 3 products worth $246.6K. Beyond Olaparib, top products include Etanercept, Nilotinib. View the complete Vama Health World LLP profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Olaparib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Olaparib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Vama Health World LLP matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 20 individual customs records matching Vama Health World LLP exporting Olaparib, covering 17 formulations to 2 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 49+ countries, 99+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Olaparib Export Data from Vama Health World LLP
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Vama Health World LLP's Olaparib exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Vama Health World LLP
Full Company Profile →
3 products · $246.6K total trade · 2 categories
Olaparib Stats
Company Overview
Top Products by Vama Health World LLP
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Vama Health World LLP.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Olaparib. For current shipment-level data, contact TransData Nexus.